Welcome to LookChem.com Sign In|Join Free

CAS

  • or

131404-69-8

Post Buying Request

131404-69-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

131404-69-8 Usage

Description

Geranylgeranylcysteine, also known as an S-polyprenyl-L-cysteine, is a unique compound where the polyprenyl moiety is specified as geranylgeranyl. This molecule is characterized by its distinct structure, which includes a cysteine amino acid bonded to a geranylgeranyl group. The presence of this group imparts specific properties to the molecule, making it potentially useful in various applications.

Uses

Used in Pharmaceutical Industry:
Geranylgeranylcysteine is used as a bioactive compound for its potential therapeutic applications. The unique structure of geranylgeranylcysteine allows it to interact with various biological targets, making it a promising candidate for the development of new drugs. Its specific interactions with cellular components can lead to the modulation of cellular processes, which may have implications in treating certain diseases or conditions.
Used in Cosmetic Industry:
In the cosmetic industry, geranylgeranylcysteine is used as an ingredient for its potential benefits to skin health. The molecule's ability to interact with cellular components may contribute to improved skin hydration, elasticity, and overall appearance. Additionally, its antioxidant properties could help protect the skin from environmental stressors, such as free radicals, which can cause damage and premature aging.
Used in Research Applications:
Geranylgeranylcysteine is also used as a research tool for studying the role of prenylation in cellular processes. Prenylation is a post-translational modification that involves the attachment of a prenyl group, such as geranylgeranyl, to a target protein. This modification can affect protein function, localization, and stability. By using geranylgeranylcysteine in experimental setups, researchers can gain insights into the mechanisms and consequences of prenylation in various biological systems.

Check Digit Verification of cas no

The CAS Registry Mumber 131404-69-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,1,4,0 and 4 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 131404-69:
(8*1)+(7*3)+(6*1)+(5*4)+(4*0)+(3*4)+(2*6)+(1*9)=88
88 % 10 = 8
So 131404-69-8 is a valid CAS Registry Number.
InChI:InChI=1/C23H39NO2S/c1-18(2)9-6-10-19(3)11-7-12-20(4)13-8-14-21(5)15-16-27-17-22(24)23(25)26/h9,11,13,15,22H,6-8,10,12,14,16-17,24H2,1-5H3,(H,25,26)/b19-11+,20-13+,21-15+/t22-/m0/s1

131404-69-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name S-geranylgeranyl-L-cysteine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:131404-69-8 SDS

131404-69-8Downstream Products

131404-69-8Relevant articles and documents

Synthesis of functionalized rab GTPases by a combination of solution- Or solid-phase lipopeptide synthesis with expressed protein ligation

Brunsveld, Luc,Watzke, Anja,Durek, Thomas,Alexandrov, Kirill,Goody, Roger S.,Waldmann, Herbert

, p. 2756 - 2772 (2005)

Prenylated proteins with non-native functionalities are generally very difficult to obtain by recombinant or enzymatic means. The semisynthesis of preparative amounts of prenylated Rab guanosine triphosphatases (GTPases) from recombinant proteins and synthetic prenylated peptides depends largely on the availability of functionalised prenylated peptides corresponding to the proteins' native structure or modifications thereof. Here, we describe and compare solution-phase and solid-phase strategies for the generation of peptides corresponding to the prenylated C terminus of Rab7 GTPase. The solid-phase with utilisation of a hydrazide linker emerges as the more favourable approach. It allows a fast and practical synthesis of pure peptides and gives a high degree of flexibility in their modification. To facilitate the analysis of semisynthetic proteins, the synthesised peptides were equipped with a fluorescent group. Using the described approach, we introduced fluorophores at several different positions of the Rab7 C terminus. The position of the incorporated fluorescent groups in the peptides did not influence the protein-ligation reaction, as the generated peptides could be ligated onto thioester-tagged Rab7. However, it was found that the positioning of the fluorescent group had an influence on the functionality of the Rab7 proteins; analysis of the interaction of the semisynthetic Rab7 proteins with REP (Rab escort protein) and GDI (guanosine diphosphate dissociation inhibitor) molecules revealed that modification of the peptide side chains or of the C-terminal isoprenoid did not significantly interfere with complex formation. However, functionalisation of the C terminus was found to have an adverse effect on complex formation and stability, possibly reflecting low structural flexibility of the Rab GDI/REP molecules in the vicinity of the lipid-binding site.

Synthesis of fluorescently labeled mono- and diprenylated Rab7 GTPase

Durek, Thomas,Alexandrov, Kirill,Goody, Roger S.,Hildebrand, Alexandra,Heinemann, Ines,Waldmann, Herbert

, p. 16368 - 16378 (2007/10/03)

Modification of proteins with isoprenoid lipids is a widespread phenomenon in eukaryotic organisms that has received much attention due to its involvement in the progression of several diseases including cancer. Progress in studies of prenylated proteins has been hampered by difficulties associated with isolation of these proteins from native or recombinant sources. Small GTPases of the Rab family represent a particularly difficult example since they are doubly C-terminally geranylgeranylated and in some cases methylated. Here, we report an efficient and versatile strategy for the synthesis of mono- and digeranylgeranylated fluorescent RabGTPases using a combination of chemical synthesis and expressed protein ligation. Using this approach we generated fluorescent mono- and diprenylated Rab7 proteins that display near-native properties and form stoichiometric complexes with their natural chaperone REP-1. We demonstrate that the complex formed from semisynthetic monoprenylated Rab7 and REP-1 represents a genuine intermediate of the Rab prenylation reaction and thus provides a unique tool for studies of the Rab prenylation mechanism. Semisynthetic Rab7 proteins were used to develop a novel fluorescence-based in vitro prenylation assay. Using this assay we dissected the mechanism of the Rab7 double-geranylgeranylation reaction mediated by Rab geranylgeranyl transferase. We conclude that the reaction follows a random sequential mechanism. These results highlight the usefulness of the semisynthetic reaction intermediates in the study of protein posttranslational modification.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 131404-69-8